Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Synthesis of human parainfluenza virus 4 nucleocapsid-like particles in yeast and their use for detection of virus-specific antibodies in human serum.

Bulavaitė A, Lasickienė R, Tamošiūnas PL, Simanavičius M, Sasnauskas K, Žvirblienė A.

Appl Microbiol Biotechnol. 2017 Apr;101(7):2991-3004. doi: 10.1007/s00253-017-8104-0. Epub 2017 Jan 19.

PMID:
28102432
2.

Yeast-generated virus-like particles as antigens for detection of human bocavirus 1-4 specific antibodies in human serum.

Tamošiūnas PL, Petraitytė-Burneikienė R, Bulavaitė A, Marcinkevičiūtė K, Simutis K, Lasickienė R, Firantienė R, Ėmužytė R, Žvirblienė A, Sasnauskas K.

Appl Microbiol Biotechnol. 2016 Jun;100(11):4935-46. doi: 10.1007/s00253-016-7336-8. Epub 2016 Feb 4.

PMID:
26846623
3.

Synthesis of human parainfluenza virus 2 nucleocapsid protein in yeast as nucleocapsid-like particles and investigation of its antigenic structure.

Bulavaitė A, Lasickienė R, Vaitiekaitė A, Sasnauskas K, Žvirblienė A.

Appl Microbiol Biotechnol. 2016 May;100(10):4523-34. doi: 10.1007/s00253-016-7330-1. Epub 2016 Jan 29.

PMID:
26821928
4.

New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.

Kucinskaite-Kodze I, Pleckaityte M, Bremer CM, Seiz PL, Zilnyte M, Bulavaite A, Mickiene G, Zvirblis G, Sasnauskas K, Glebe D, Zvirbliene A.

Virus Res. 2016 Jan 4;211:209-21. doi: 10.1016/j.virusres.2015.10.024. Epub 2015 Nov 2.

PMID:
26541316
5.

Saliva as an alternative specimen for detection of Schmallenberg virus-specific antibodies in bovines.

Lazutka J, Spakova A, Sereika V, Lelesius R, Sasnauskas K, Petraityte-Burneikiene R.

BMC Vet Res. 2015 Sep 15;11:237. doi: 10.1186/s12917-015-0552-0.

6.

Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.

Norkiene M, Stonyte J, Ziogiene D, Mazeike E, Sasnauskas K, Gedvilaite A.

BMC Biotechnol. 2015 Aug 4;15:68. doi: 10.1186/s12896-015-0187-z.

7.

Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.

Nainys J, Lasickiene R, Petraityte-Burneikiene R, Dabrisius J, Lelesius R, Sereika V, Zvirbliene A, Sasnauskas K, Gedvilaite A.

BMC Biotechnol. 2014 Dec 9;14:100. doi: 10.1186/s12896-014-0100-1.

8.

Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies.

Tamošiūnas PL, Petraitytė-Burneikienė R, Lasickienė R, Akatov A, Kundrotas G, Sereika V, Lelešius R, Žvirblienė A, Sasnauskas K.

J Immunol Res. 2014;2014:573531. doi: 10.1155/2014/573531. Epub 2014 Jun 19.

9.

Generation of recombinant Schmallenberg virus nucleocapsid protein in yeast and development of virus-specific monoclonal antibodies.

Lazutka J, Zvirbliene A, Dalgediene I, Petraityte-Burneikiene R, Spakova A, Sereika V, Lelesius R, Wernike K, Beer M, Sasnauskas K.

J Immunol Res. 2014;2014:160316. doi: 10.1155/2014/160316. Epub 2014 May 29.

10.

Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.

Skrastina D, Petrovskis I, Petraityte R, Sominskaya I, Ose V, Lieknina I, Bogans J, Sasnauskas K, Pumpens P.

Clin Vaccine Immunol. 2013 Nov;20(11):1719-28. doi: 10.1128/CVI.00533-13. Epub 2013 Sep 4.

11.

Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.

Tamošiūnas PL, Simutis K, Kodzė I, Firantienė R, Emužytė R, Petraitytė-Burneikienė R, Zvirblienė A, Sasnauskas K.

Intervirology. 2013;56(5):271-7. doi: 10.1159/000353112. Epub 2013 Aug 7.

12.

Hantavirus infection among wild small mammals in Vellore, south India.

Chandy S, Ulrich RG, Schlegel M, Petraityte R, Sasnauskas K, Prakash DJ, Balraj V, Abraham P, Sridharan G.

Zoonoses Public Health. 2013 Aug;60(5):336-40. doi: 10.1111/j.1863-2378.2012.01532.x. Epub 2012 Aug 1.

PMID:
22856552
13.

Novel serological tools for detection of Thottapalayam virus, a Soricomorpha-borne hantavirus.

Schlegel M, Tegshduuren E, Yoshimatsu K, Petraityte R, Sasnauskas K, Hammerschmidt B, Friedrich R, Mertens M, Groschup MH, Arai S, Endo R, Shimizu K, Koma T, Yasuda S, Ishihara C, Ulrich RG, Arikawa J, Köllner B.

Arch Virol. 2012 Nov;157(11):2179-87. doi: 10.1007/s00705-012-1405-9. Epub 2012 Jul 25.

PMID:
22828778
14.

A point-of-care test for measles diagnosis: detection of measles-specific IgM antibodies and viral nucleic acid.

Warrener L, Slibinskas R, Chua KB, Nigatu W, Brown KE, Sasnauskas K, Samuel D, Brown D.

Bull World Health Organ. 2011 Sep 1;89(9):675-82. doi: 10.2471/BLT.11.088427. Epub 2011 Jul 5.

15.

Generation of recombinant metapneumovirus nucleocapsid protein as nucleocapsid-like particles and development of virus-specific monoclonal antibodies.

Petraitytė-Burneikienė R, Nalivaiko K, Lasickienė R, Firantienė R, Emužytė R, Sasnauskas K, Zvirblienė A.

Virus Res. 2011 Nov;161(2):131-9. doi: 10.1016/j.virusres.2011.07.009. Epub 2011 Jul 30.

PMID:
21827798
16.

Overexpression of human calnexin in yeast improves measles surface glycoprotein solubility.

Ciplys E, Sasnauskas K, Slibinskas R.

FEMS Yeast Res. 2011 Sep;11(6):514-23. doi: 10.1111/j.1567-1364.2011.00742.x. Epub 2011 Jun 27.

17.

Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava-Belgrade hantaviruses.

Mertens M, Hofmann J, Petraityte-Burneikiene R, Ziller M, Sasnauskas K, Friedrich R, Niederstrasser O, Krüger DH, Groschup MH, Petri E, Werdermann S, Ulrich RG.

Med Microbiol Immunol. 2011 Nov;200(4):263-8. doi: 10.1007/s00430-011-0203-4. Epub 2011 May 25.

PMID:
21611907
18.

Overexpression of human virus surface glycoprotein precursors induces cytosolic unfolded protein response in Saccharomyces cerevisiae.

Ciplys E, Samuel D, Juozapaitis M, Sasnauskas K, Slibinskas R.

Microb Cell Fact. 2011 May 19;10:37. doi: 10.1186/1475-2859-10-37.

19.

Characterization of monoclonal antibodies against hantavirus nucleocapsid protein and their use for immunohistochemistry on rodent and human samples.

Kucinskaite-Kodze I, Petraityte-Burneikiene R, Zvirbliene A, Hjelle B, Medina RA, Gedvilaite A, Razanskiene A, Schmidt-Chanasit J, Mertens M, Padula P, Sasnauskas K, Ulrich RG.

Arch Virol. 2011 Mar;156(3):443-56. doi: 10.1007/s00705-010-0879-6. Epub 2010 Dec 16.

PMID:
21161552
20.

Different patterns of BK and JC polyomavirus reactivation following renal transplantation.

Saundh BK, Tibble S, Baker R, Sasnauskas K, Harris M, Hale A.

J Clin Pathol. 2010 Aug;63(8):714-8. doi: 10.1136/jcp.2009.074864.

PMID:
20702473
21.

Interaction of hepatitis B virus core protein with human GIPC1.

Razanskas R, Sasnauskas K.

Arch Virol. 2010 Feb;155(2):247-50. doi: 10.1007/s00705-009-0561-z. Epub 2009 Nov 29.

PMID:
20091192
22.

Development and evaluation of a rapid immunochromatographic test for mumps-specific IgM in oral fluid specimens and use as a matrix for preserving viral nucleic acid for RT-PCR.

Warrener L, Slibinskas R, Brown D, Sasnauskas K, Samuel D.

J Med Virol. 2010 Mar;82(3):485-93. doi: 10.1002/jmv.21693.

PMID:
20087926
23.

Human rhinoviruses, allergy, and asthma: a clinical approach.

Emuzyte R, Firantiene R, Petraityte R, Sasnauskas K.

Medicina (Kaunas). 2009;45(11):839-47. Review.

24.

Novel monoclonal antibodies against Menangle virus nucleocapsid protein.

Zvirbliene A, Kucinskaite-Kodze I, Juozapaitis M, Lasickiene R, Gritenaite D, Russell G, Bingham J, Michalski WP, Sasnauskas K.

Arch Virol. 2010;155(1):13-8. doi: 10.1007/s00705-009-0543-1. Epub 2009 Nov 8.

PMID:
19898771
25.

Extensive host sharing of central European Tula virus.

Schmidt-Chanasit J, Essbauer S, Petraityte R, Yoshimatsu K, Tackmann K, Conraths FJ, Sasnauskas K, Arikawa J, Thomas A, Pfeffer M, Scharninghausen JJ, Splettstoesser W, Wenk M, Heckel G, Ulrich RG.

J Virol. 2010 Jan;84(1):459-74. doi: 10.1128/JVI.01226-09.

26.

A novel human protein is able to interact with hepatitis B virus core deletion mutant but not with the wild-type protein.

Razanskas R, Sasnauskas K.

Virus Res. 2009 Dec;146(1-2):130-4. doi: 10.1016/j.virusres.2009.09.008. Epub 2009 Sep 19.

PMID:
19770013
27.

Generation of Tioman virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae.

Petraityte R, Tamosiunas PL, Juozapaitis M, Zvirbliene A, Sasnauskas K, Shiell B, Russell G, Bingham J, Michalski WP.

Virus Res. 2009 Oct;145(1):92-6. doi: 10.1016/j.virusres.2009.06.013. Epub 2009 Jun 25. Erratum in: Virus Res. 2009 Dec;146(1-2):141.

PMID:
19559738
28.

Mapping of an antigenic site on the nucleocapsid protein of human parainfluenza virus type 3.

Zvirbliene A, Sezaite I, Pleckaityte M, Kucinskaite-Kodze I, Juozapaitis M, Sasnauskas K.

Viral Immunol. 2009 Jun;22(3):181-8. doi: 10.1089/vim.2008.0106.

PMID:
19435414
29.

Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.

Dorn DC, Lawatscheck R, Zvirbliene A, Aleksaite E, Pecher G, Sasnauskas K, Ozel M, Raftery M, Schönrich G, Ulrich RG, Gedvilaite A.

Viral Immunol. 2008 Mar;21(1):12-27. doi: 10.1089/vim.2007.0085.

PMID:
18355119
30.

High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.

Skrastina D, Bulavaite A, Sominskaya I, Kovalevska L, Ose V, Priede D, Pumpens P, Sasnauskas K.

Vaccine. 2008 Apr 7;26(16):1972-81. doi: 10.1016/j.vaccine.2008.02.030. Epub 2008 Feb 26.

PMID:
18343539
31.

Synthesis of recombinant human parainfluenza virus 1 and 3 nucleocapsid proteins in yeast Saccharomyces cerevisiae.

Juozapaitis M, Zvirbliene A, Kucinskaite I, Sezaite I, Slibinskas R, Coiras M, de Ory Manchon F, López-Huertas MR, Pérez-Breña P, Staniulis J, Narkeviciute I, Sasnauskas K.

Virus Res. 2008 May;133(2):178-86. doi: 10.1016/j.virusres.2007.12.016. Epub 2008 Feb 4.

PMID:
18249456
32.

Seroprevalence of SV40-like polyomavirus infections in captive and free-ranging macaque species.

Verschoor EJ, Niphuis H, Fagrouch Z, Christian P, Sasnauskas K, Pizarro MC, Heeney JL.

J Med Primatol. 2008 Aug;37(4):196-201. doi: 10.1111/j.1600-0684.2007.00276.x. Epub 2008 Jan 9.

PMID:
18194222
33.

Development and evaluation of serological assays for detection of Hantaanvirus-specific antibodies in human sera using yeast-expressed nucleocapsid protein.

Petraityte R, Yang H, Hunjan R, Razanskiene A, Dhanilall P, Ulrich RG, Sasnauskas K, Jin L.

J Virol Methods. 2008 Mar;148(1-2):89-95.

PMID:
18077007
34.

[Prevalence of antibodies to hantavirus among hemodialysis patients with end-stage renal failure in Kaunas and its district].

Dargevicius A, Petraityte R, Sribikiene B, Sileikiene E, Razukeviciene L, Ziginskiene E, Vorobjoviene R, Razanskiene A, Sasnauskas K, Bumblyte IA, Kuzminskis V.

Medicina (Kaunas). 2007;43 Suppl 1:72-6. Lithuanian.

35.

Profiling of external metabolites during production of hantavirus nucleocapsid protein with recombinant Saccharomyces cerevisiae.

Antoniukas L, Grammel H, Sasnauskas K, Reichl U.

Biotechnol Lett. 2008 Mar;30(3):415-20. Epub 2007 Nov 6.

36.

Nephropathia epidemica in metropolitan area, Germany.

Essbauer SS, Schmidt-Chanasit J, Madeja EL, Wegener W, Friedrich R, Petraityte R, Sasnauskas K, Jacob J, Koch J, Dobler G, Conraths FJ, Pfeffer M, Pitra C, Ulrich RG.

Emerg Infect Dis. 2007 Aug;13(8):1271-3. No abstract available.

37.

Chimeric polyomavirus-derived virus-like particles: the immunogenicity of an inserted peptide applied without adjuvant to mice depends on its insertion site and its flanking linker sequence.

Lawatscheck R, Aleksaite E, Schenk JA, Micheel B, Jandrig B, Holland G, Sasnauskas K, Gedvilaite A, Ulrich RG.

Viral Immunol. 2007 Sep;20(3):453-60.

PMID:
17931115
38.

Use of Saccharomyces cerevisiae-expressed recombinant nucleocapsid protein to detect Hantaan virus-specific immunoglobulin G (IgG) and IgM in oral fluid.

Petraityte R, Jin L, Hunjan R, Razanskiene A, Zvirbliene A, Sasnauskas K.

Clin Vaccine Immunol. 2007 Dec;14(12):1603-8. Epub 2007 Oct 3.

39.

Antigenic characterisation of yeast-expressed lyssavirus nucleoproteins.

Kucinskaite I, Juozapaitis M, Serva A, Zvirbliene A, Johnson N, Staniulis J, Fooks AR, Müller T, Sasnauskas K, Ulrich RG.

Virus Genes. 2007 Dec;35(3):521-9. Epub 2007 Jul 6.

PMID:
17619134
40.

Generation of menangle virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae.

Juozapaitis M, Serva A, Kucinskaite I, Zvirbliene A, Slibinskas R, Staniulis J, Sasnauskas K, Shiell BJ, Bowden TR, Michalski WP.

J Biotechnol. 2007 Jul 15;130(4):441-7. Epub 2007 May 24.

PMID:
17602774
41.

No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.

Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J.

Int J Cancer. 2007 Sep 1;121(5):1098-102.

42.

Generation of henipavirus nucleocapsid proteins in yeast Saccharomyces cerevisiae.

Juozapaitis M, Serva A, Zvirbliene A, Slibinskas R, Staniulis J, Sasnauskas K, Shiell BJ, Wang LF, Michalski WP.

Virus Res. 2007 Mar;124(1-2):95-102. Epub 2006 Nov 22.

PMID:
17123657
43.

Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.

Meisel H, Wolbert A, Razanskiene A, Marg A, Kazaks A, Sasnauskas K, Pauli G, Ulrich R, Krüger DH.

Clin Vaccine Immunol. 2006 Dec;13(12):1349-57. Epub 2006 Oct 4.

44.

Mapping of B cell epitopes in measles virus nucleocapsid protein.

Zvirbliene A, Kucinskaite I, Sezaite I, Samuel D, Sasnauskas K.

Arch Virol. 2007 Jan;152(1):25-39. Epub 2006 Aug 31.

PMID:
16944047
45.

Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.

Gedvilaite A, Dorn DC, Sasnauskas K, Pecher G, Bulavaite A, Lawatscheck R, Staniulis J, Dalianis T, Ramqvist T, Schönrich G, Raftery MJ, Ulrich R.

Virology. 2006 Oct 25;354(2):252-60. Epub 2006 Aug 10.

46.

Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.

Zielonka A, Gedvilaite A, Ulrich R, Lüschow D, Sasnauskas K, Müller H, Johne R.

Virus Res. 2006 Sep;120(1-2):128-37. Epub 2006 Jun 15.

PMID:
16780983
47.

Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity.

Gedvilaite A, Aleksaite E, Staniulis J, Ulrich R, Sasnauskas K.

Arch Virol. 2006 Sep;151(9):1811-25. Epub 2006 Mar 30.

PMID:
16575481
48.

Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.

Zvirbliene A, Samonskyte L, Gedvilaite A, Voronkova T, Ulrich R, Sasnauskas K.

J Immunol Methods. 2006 Apr 20;311(1-2):57-70. Epub 2006 Feb 20.

PMID:
16516908
49.

Assembly of bacteriophage Qbeta virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris.

Freivalds J, Dislers A, Ose V, Skrastina D, Cielens I, Pumpens P, Sasnauskas K, Kazaks A.

J Biotechnol. 2006 May 29;123(3):297-303. Epub 2006 Jan 6.

PMID:
16406160
50.

Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.

Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grün S, Bulavaite A, Sasnauskas K, Gerlich WH.

Gastroenterology. 2005 Jul;129(1):234-45.

PMID:
16012950

Supplemental Content

Loading ...
Support Center